Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
Y-mAbs Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
| Table 1 – Newly Registered Securities | |||||||
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
Fees to be Paid | Equity | Common Stock, $0.0001 par value per share, 2018 Equity Incentive Plan | Other(2) | 1,746,884(3) | $16.73 | $29,225,369.32 | $0.00014760 | $4,313.66 |
| Total Offering Amounts | 1,746,884 | – | $29,225,369.32 | – | $4,313.66 | ||
| Total Fees Previously Paid | | – | – | – | – | ||
| Total Fee Offsets | | – | – | – | – | ||
| Net Fee Due | | – | – | – | $4,313.66 | ||
(1) | Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional shares of Common Stock, par value $0.0001 (“Common Stock”) of Y-mAbs Therapeutics, Inc. (the “Registrant”) that become issuable under the plans set forth herein by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Common Stock, as applicable. |
(2) | Estimated in accordance with Rules 457(c) and 457(h) solely for purposes of calculating the registration fee based on the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Select Market on February 22, 2024. |
(3) | Represents 1,746,884 additional shares of Common Stock that were automatically added to the shares authorized for issuance under the Registrant’s 2018 Equity Incentive Plan (the “2018 EIP”) on January 1, 2024, pursuant to an annual “evergreen” increase provision contained in the 2018 EIP. Pursuant to such provision, the number of shares reserved for issuance under the 2018 EIP will automatically increase on the first day of each calendar year, starting on January 1, 2019 and continuing through January 1, 2028, by the lesser of (a) four percent (4%) of the total number of shares of the Registrant’s common stock of all classes outstanding on December 31st of the immediately preceding calendar year; and (b) a smaller number of shares determined by the Registrant’s board of directors. |
